{"id":"W4239984345","doi":"10.1007/s12325-014-0150-8","title":"Erratum to: Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis","year":2014,"lang":"en","type":"erratum","venue":"Advances in Therapy","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Exemestane; Medicine; Everolimus; Internal medicine; Oncology; Breast cancer; Postmenopausal women; Progression-free survival; Aromatase; Overall survival; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001466728,0.0005940795,0.001025609,0.001079388,0.0005246738,0.0009077031,0.000641801,0.001215008,0.01089174],"category_scores_gemma":[0.009133639,0.0002974462,0.0009983149,0.0007062649,0.0002932087,0.0005456876,0.0002751227,0.002127964,0.003993807],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001215929,"about_ca_system_score_gemma":0.001404049,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004914072,"about_ca_topic_score_gemma":0.01026464,"domain_scores_codex":[0.9993292,0.00008559771,0.00016389,0.00008012906,0.0002673869,0.00007373763],"domain_scores_gemma":[0.9975548,0.0009653526,0.0002527054,0.000133831,0.000913087,0.0001803099],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002426286,0.0001067205,0.01027128,0.0006237654,0.0002711808,0.001582501,0.00003890771,0.0004784747,0.0003613472,0.0007961497,0.9222451,0.06079822],"study_design_scores_gemma":[0.00128514,0.0008734495,0.05234669,0.001222813,0.001642647,0.006187489,0.0002965947,0.002086596,0.002517922,0.001925233,0.9295036,0.0001117018],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"other","genre_scores_codex":[0.0331057,0.02699374,0.003860205,0.1489617,0.7312309,0.0003802679,0.02845768,0.000680669,0.02632906],"genre_scores_gemma":[0.2381473,0.03150947,0.01558353,0.193405,0.1097803,0.0005690421,0.03256638,0.001472238,0.3769667],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01089174,"threshold_uncertainty_score":0.0364365,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007630919257924771,"score_gpt":0.2911378448630639,"score_spread":0.2835069256051391,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}